查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
基因检测服务市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按服务类型、疾病、服务提供者和地理位置
市场调查报告书
商品编码
1424127

基因检测服务市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按服务类型、疾病、服务提供者和地理位置

Genetic Testing Services Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type, Disease, Service Provider, and Geography
出版日期: | 出版商: The Insight Partners | 英文 193 Pages | 订单完成后即时交付

价格

基因检测服务市场规模预计将从2022年的34.25亿美元成长到2030年的105.56亿美元；预计2022-2030年CAGR为15.1%。

基因检测服务市场的成长归因于遗传疾病的日益流行、对个人化药物的认识和接受程度的提高以及对直接面向消费者的基因检测的日益偏好。然而，基因检测的社会和伦理影响以及基因服务的可负担性阻碍了市场的成长。

中国、印度、墨西哥和巴西等新兴国家为市场参与者提供了巨大的成长机会。高成长可归因于公共医疗支出的增加、医疗基础设施的改善以及目标患者群体的庞大。由于发展中经济体对遗传性疾病及其早期诊断的认识不断提高，对基因检测的需求也增加。

高收入国家和中低收入国家的遗传服务品质和可得性可能有所不同。例如，遗传服务在美国、澳洲、加拿大、英国和其他欧洲国家都很先进、成熟且广泛。这些服务包括新生儿筛检、携带者识别筛检和产前诊断。然而，在许多高收入国家，在多种环境下提供的遗传服务仍需要改进的评估系统。

基因检测程序的简单性和适用性使亚太地区和全球其他发展中地区的研发活动受益。主要市场参与者专注于策略和倡议，例如协议、合作、伙伴关係和扩张，以提高这些国家的产品可用性、可及性和分销网络。这将有助于他们满足日益增长的早期诊断和治疗需求。例如，2019年，巴西领先的基因检测实验室之一GENOMIKA与Veritas达成协议，将全基因组定序以及与预防医学和临床遗传学这些检测相关的所有服务纳入其产品组合。

中国政府将基因组学确定为经济社会发展第十四个五年规​​划（2016-2020）的重要策略领域。 2016年，中国科学院启动了精准医学计划，这是一个为期14年、价值92亿美元的项目，目标是到2030年对超过1亿个人类基因组进行测序。2017年12月，中国科技部与人类基因组合作记录 10 万人基因组成的研究计画。研究人员希望利用九个不同少数群体的遗传资料来解码基因内的遗传讯息。此外，发展中经济体消费者对 DTC 基因检测的认识不断提高，为 DTC 产业提供了成长机会。

因此，预计发展中国家的新兴市场将为市场参与者提供重大成长机会，并在预测期内促进市场成长。

截至 2018 年，市场上已有约 75,000 种基因检测产品，每天有近 10 种新检测产品进入市场。根据 2023 年发表的研究《2012-2022 年美国基因检测可用性趋势》，美国和全球分别有约 129,624 项和 197,779 项基因检测已可供使用并提交给基因检测登记处截至2022 年11 月。这些测试已从单基因测试扩展到观察多个基因的面板。为了解决日益严重的健康资料耗尽问题，医学领域越来越多地围绕着增强的临床工具，例如人工智慧（AI）和机器学习，这些工具被认为是提高基因组医学接受度的一种方法。如今，许多公司已转向机器学习来处理正确分析和理解放射学和心臟病学等领域的临床资料所需的大量资料。

市场上许多面向消费者的基因检测技术都使用机器学习或人工智慧来发挥作用。从很多方面来说，疾病基因检测都是机器学习的完美领域，因为这些程式需要处理大量资料。例如，研究人类基因组包括读取数十亿位元讯息，而在引入机器学习之前，其中许多任务都非常棘手。人工智慧在分析遗传资料和支援临床专家诊断方面具有巨大潜力。

谷歌有一个名为 Deep Variant 的程序，现在可以用来彻底绘製人类基因组图，并可以用于一个人的全部遗传资讯。此外，美国国立卫生研究院等机构正在研究机器学习和人工智慧如何帮助人们更好地理解遗传学和基因组学。因此，透过成功整合这些工具，临床医生将能够更有效率地诊断罕见遗传疾病。

基于服务提供者的见解

根据服务提供者，基因检测服务市场分为一般检测服务和基于液体活检的 CGP、MRD 和 MCED 服务。 2022年，通用测试服务领域占最大市场份额，预计2022-2023年复合CAGR最高。遗传和分子检测对于检测许多遗传性疾病、与遗传相关的躯体或后天性疾病以及药物遗传学反应至关重要。多种基因测试可用于分析遗传、染色体或蛋白质修饰。在选择合适的测试时，医疗保健提供者会考虑几个因素，包括疑似病症和通常与之相关的遗传变异。市面上可用的几种类型的基因测试是基于分子、染色体和生化机制以及基因表现等。

一般基因检测是对头髮、皮肤、血液、羊水（怀孕期间胎儿周围的液体）或其他组织样本进行的。 COVID-19 PCR 测试使用与病毒遗传物质片段匹配的引物，可以扩增从样本中提取的遗传物质，以检测病毒的存在。

疾病管制与预防中心、美国食品药物管理局以及世界卫生组织是准备基因检测服务市场报告时参考的主要和次要来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：基因检测服务市场格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：基因检测服务市场 - 主要产业动态

  • 主要市场驱动因素
    • 遗传性疾病盛行率上升
    • 提高对个人化药物的认识和接受度
    • 对直接面向消费者 (DTC) 的基因检测的偏好日益增长
  • 市场限制
    • 基因检测的社会和伦理影响
    • 遗传服务的承受能力
  • 市场机会
    • 发展中国家尚未开发的新兴市场
  • 未来的趋势
    • 人工智慧驱动的基因检测
  • 影响分析：

第 6 章：基因检测服务市场 - 全球市场分析

  • 基因检测服务市场收入，2022 - 2030

第 7 章：全球基因检测服务市场 - 收入和 2030 年预测 - 按服务类型

  • 概述
  • 2022 年及 2030 年基因检测服务市场收入份额（按服务类型划分）（%）
  • 预测测试
  • 运营商测试
  • 产前检测
  • 新生儿筛检
  • 诊断基因检测
  • 其他的

第 8 章：全球基因检测服务市场 - 收入和 2030 年预测 - 按疾病分类

  • 概述
  • 2022 年和 2030 年按疾病分類的基因检测服务市场收入份额 (%)
  • 癌症
  • 心血管疾病
  • 代谢性疾病
  • 其他疾病

第 9 章：全球基因检测服务市场 - 收入和 2030 年预测 - 按服务提供者

  • 概述
  • 2022 年和 2030 年基因检测服务市场收入份额（按服务提供者划分）（%）
  • 通用测试服务
  • 基于液体活检的 CGP、MRD 和 MCED 服务

第 10 章：基因检测服务市场 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：基因检测服务市场-产业格局

  • 概述
  • 基因检测服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene AG
  • Bio-Rad Laboratories Inc

第 13 章：附录

Product Code: TIPHE100001383

The genetic testing services market size is expected to grow from US$ 3.425 billion in 2022 to US$ 10.556 billion by 2030; it is estimated to record a CAGR of 15.1% during 2022-2030.

The growth of the genetic testing services market is attributed to the growing prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer genetic testing. However, the social and ethical implications of genetic testing and the affordability of genetic services hinder market growth.

Emerging countries such as China, India, Mexico, and Brazil offer significant growth opportunities to market players. The high growth can be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders and their early diagnosis in developing economies.

The quality and availability of genetic services may differ between high-income and low- to middle-income countries. For instance, genetic services are well-advanced, established, and extensive in the US, Australia, Canada, the UK, and other European countries. These services include newborn screening, carrier identification screening, and prenatal diagnosis. Yet, in many high-income countries, genetic services offered in multiple settings still need improved assessment systems.

The ease and applicability of genetic testing procedures have benefitted R&D activities in Asia Pacific and other developing regions worldwide. Major market players focus on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries. This will help them address the growing need for early diagnosis and treatment. For instance, in 2019, GENOMIKA, one of Brazil's leading genetic testing laboratories, reached an agreement with Veritas to incorporate Whole Genome Sequencing and all the services associated with these tests in preventive medicine and clinical genetics into its portfolio.

The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016-2020) for economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry.

Therefore, emerging markets in developing countries are anticipated to offer significant growth opportunities to the players operating in the market and boost the market growth during the forecast period.

As of 2018, there were ~75,000 genetic tests available in the market, with nearly 10 new tests entering the market every day. As per the study "Trends in Availability of Genetic Tests in the United States, 2012-2022," published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to analyze and understand clinical data correctly in fields such as radiology and cardiology.

Many of the consumer-facing genetic testing technologies available in the market use machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and many of these tasks were pretty tricky before the introduction of machine learning. AI offers great potential in analyzing genetic data and supporting clinical specialists in diagnosing.

Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways machine learning and AI can add to a better understanding of genetics and genomics. Thus, by successfully integrating these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively.

Service Provider -Based Insights

Based on the service provider, the genetic testing services market is segmented into general testing services and liquid biopsy-based CGP, MRD, and MCED services. In 2022, the general testing services segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2023. Genetic and molecular testing is fundamental for detecting many inherited disorders, somatic or acquired diseases with genetic associations, and pharmacogenetic responses. Multiple genetic tests are available to analyze genetic, chromosomal, or protein modifications. When selecting the suitable test, a healthcare provider considers several factors, including suspected conditions and genetic variations typically associated with them. Several types of genetic tests available in the market are based on molecular, chromosomal, and biochemical mechanisms, as well as gene expressions, among others.

General genetic tests are performed on hair, skin, blood, amniotic fluid (the fluid surrounding a fetus during pregnancy), or other tissue samples. COVID-19 PCR tests use primers matching a virus's genetic material segment, allowing the amplification of the genetic material extracted from samples to detect the presence of the virus.

Centers for Disease Control and Prevention, the US Food and Drug Administration, and the World Health Organization are among the primary and secondary sources referred to while preparing the genetic testing services market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the genetic testing services market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Genetic Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Genetic Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Prevalence of Genetic Diseases
    • 5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 Social and Ethical Implications of Genetic Testing
    • 5.2.2 Affordability of Genetic Services
  • 5.3 Market Opportunities
    • 5.3.1 Untapped Emerging Markets in Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Artificial Intelligence-Powered Genetic Testing
  • 5.5 Impact Analysis:

6. Genetic Testing Services Market - Global Market Analysis

  • 6.1 Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Global Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Type

  • 7.1 Overview
  • 7.2 Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • 7.3 Predictive Testing
    • 7.3.1 Overview
    • 7.3.2 Predictive Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Carrier Testing
    • 7.4.1 Overview
    • 7.4.2 Carrier Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Prenatal Testing
    • 7.5.1 Overview
    • 7.5.2 Prenatal Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Newborn Screening
    • 7.6.1 Overview
    • 7.6.2 Newborn Screening: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Diagnostic Genetic Testing
    • 7.7.1 Overview
    • 7.7.2 Diagnostic Genetic Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Genetic Testing Services Market - Revenue and Forecast to 2030 - by Disease

  • 8.1 Overview
  • 8.2 Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • 8.3 Cancer
    • 8.3.1 Overview
    • 8.3.2 Cancer: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cardiovascular Diseases
    • 8.4.1 Overview
    • 8.4.2 Cardiovascular Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Metabolic Diseases
    • 8.5.1 Overview
    • 8.5.2 Metabolic Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Diseases
    • 8.6.1 Overview
    • 8.6.2 Other Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Provider

  • 9.1 Overview
  • 9.2 Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • 9.3 General Testing Service
    • 9.3.1 Overview
    • 9.3.2 General Testing Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.1 Hospital-Based Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.2 Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.3 Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Liquid biopsy-based CGP, MRD, and MCED Service
    • 9.4.1 Overview
    • 9.4.2 Liquid biopsy-based CGP, MRD, and MCED Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 Hospital-Based Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.2 Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.3 Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Genetic Testing Services Market - Geographical Analysis

  • 10.1 North America Genetic Testing Services Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.3 North America: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.1.4 North America: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.1.5 North America: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.5.1 North America: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.5.2 North America: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.1.6 North America Genetic Testing Services Market, by Country
      • 10.1.6.1 US
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.1.3 US: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.1.6.1.4 US: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.1.6.1.5 US: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.6.2 Canada
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.2.3 Canada: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.1.6.2.4 Canada: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.1.6.2.5 Canada: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.1.6.3 Mexico
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.3.3 Mexico: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.1.6.3.4 Mexico: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.1.6.3.5 Mexico: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.2 Europe Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.2.1 Overview
    • 10.2.2 Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.2.3 Europe: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.2.4 Europe: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.2.5 Europe: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.5.1 Europe: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.5.2 Europe: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.2.6 Europe Genetic Testing Services Market, by Country
      • 10.2.6.1 UK
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.1.3 UK: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.1.4 UK: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.1.5 UK: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.2 Germany
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 Germany Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.2.3 Germany: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.2.4 Germany: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.2.5 Germany: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.3 France
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.3.3 France: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.3.4 France: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.3.5 France: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.4 Italy
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.4.3 Italy: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.4.4 Italy: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.4.5 Italy: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.5 Spain
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.5.3 Spain: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.5.4 Spain: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.5.5 Spain: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.2.6.6 Rest of Europe
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.6.3 Rest of Europe: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.3.3 Asia Pacific: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.3.4 Asia Pacific: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.3.5 Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.5.1 Asia Pacific: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.5.2 Asia Pacific: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.3.6 Asia Pacific Genetic Testing Services Market, by Country
      • 10.3.6.1 China
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.1.3 China: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.1.4 China: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.1.5 China: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.2 Japan
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.2.3 Japan: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.2.4 Japan: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.2.5 Japan: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.3 India
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.3.3 India: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.3.4 India: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.3.5 India: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.4 Australia
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.4.3 Australia: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.4.4 Australia: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.4.5 Australia: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.5 South Korea
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.5.3 South Korea: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.5.4 South Korea: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.5.5 South Korea: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.6.3 Rest of Asia Pacific: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.4.3 Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.5.1 Middle East & Africa: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.5.2 Middle East & Africa: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020-2030 (US$ Million)
    • 10.4.6 Middle East & Africa Genetic Testing Services Market, by Country
      • 10.4.6.1 Saudi Arabia
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.1.3 Saudi Arabia: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.1.4 Saudi Arabia: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.1.5 Saudi Arabia: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.6.2 UAE
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 UAE Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.2.3 UAE: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.2.4 UAE: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.2.5 UAE: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.6.3 South Africa
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.3.3 South Africa: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.3.4 South Africa: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.3.5 South Africa: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.4.3 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.4.6.4.5 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
  • 10.5 South & Central America Genetic Testing Services Market, Revenue and Forecast to 2030
    • 10.5.1 Overview
    • 10.5.2 South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.5.3 South & Central America: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
    • 10.5.4 South & Central America: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
    • 10.5.5 South & Central America: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.5.1 South & Central America: General Testing Service, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.5.2 South & Central America: Liquid biopsy-based CGP, MRD, and MCED Services, by Service Provider, 2020-2030 (US$ Million)
    • 10.5.6 South & Central America Genetic Testing Services Market, by Country
      • 10.5.6.1 Brazil
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.1.3 Brazil: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.5.6.1.4 Brazil: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.5.6.1.5 Brazil: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.6.2 Argentina
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.2.3 Argentina: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.5.6.2.4 Argentina: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.5.6.2.5 Argentina: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 10.5.6.3 Rest of South & Central America
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.3.3 Rest of South & Central America: Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 10.5.6.3.5 Rest of South & Central America: Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)

11. Genetic Testing Services Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Genetic Testing Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Eurofins Scientific SE
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Exact Sciences Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Laboratory Corp of America Holdings
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4andMe Holding Co
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Ambry Genetics Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Quest Diagnostics Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Illumina Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 F. Hoffmann-La Roche Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 NeoGenomics Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Centogene AG
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Bio-Rad Laboratories Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Genetic Testing Services Market Segmentation
  • Table 2. North America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America General Testing Service Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Europe General Testing Service Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. UK Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. UK Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. UK Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Germany Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Germany Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. France Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. France Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Italy Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Italy Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Italy Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Spain Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Spain Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Spain Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Rest of Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Asia Pacific Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Asia Pacific Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. China Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. China Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. China Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Japan Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Japan Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Japan Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. India Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. India Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. India Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Australia Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Australia Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Australia Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. South Korea Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. South Korea Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. South Korea Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Rest of Asia Pacific Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Rest of Asia Pacific Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Rest of Asia Pacific Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Middle East & Africa Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Middle East & Africa Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Saudi Arabia Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Saudi Arabia Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Saudi Arabia Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. UAE Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. UAE Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. UAE Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. South Africa Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. South Africa Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. South Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Rest of Middle East & Africa Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Rest of Middle East & Africa Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Rest of Middle East & Africa Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South & Central America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South & Central America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Brazil Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Brazil Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Brazil Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. Argentina Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. Argentina Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Argentina Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of South & Central America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of South & Central America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 94. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 95. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. Genetic Testing Services Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Genetic Testing Services Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Genetic Testing Services Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • Figure 8. Predictive Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Prenatal Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Newborn Screening: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Diagnostic Genetic Testing: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • Figure 15. Cancer: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Cardiovascular Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Metabolic Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Diseases: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • Figure 20. General Testing Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. General Testing Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Liquid biopsy-based CGP, MRD, and MCED Service: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Hospital-Based Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Diagnostic Laboratories: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Others: Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. North America: Genetic Testing Services Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 29. North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. North America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 31. US Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Canada Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Mexico Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Europe Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 35. Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Europe Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 37. UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Germany Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Asia Pacific Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 44. Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Asia Pacific Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 46. China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. Middle East & Africa Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 53. Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Middle East & Africa Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 55. Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. UAE Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. Rest of Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. South & Central America Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 60. South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. South & Central America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 62. Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 63. Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 64. Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 65. Growth Strategies in Genetic Testing Services Market